Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1194)
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
450
Price
$69.09
Total Value
$31.09K
Shares Held After
575,686
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,333
Price
$68.38
Total Value
$569.79K
Shares Held After
576,136
% of Holdings
1.4%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
11,217
Price
$67.50
Total Value
$757.09K
Shares Held After
584,469
% of Holdings
1.9%
Atara Biotherapeutics, Inc. (ATRA)
EcoR1 Capital, LLC — 10% Owner
Shares
507,407
Price
$9.35
Total Value
$4.74M
Shares Held After
1,552,000
% of Holdings
32.7%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Friberg Gregory R — EVP, Chief R&D Officer
Shares
3,281
Price
$53.85
Total Value
$176.68K
Shares Held After
51,818
% of Holdings
6.0%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
271,495
Price
$40.12
Total Value
$10.89M
Shares Held After
6,437,733
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$597.54
Total Value
$95.61K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$589.63
Total Value
$94.34K
Shares Held After
40,673
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$588.86
Total Value
$188.43K
Shares Held After
40,833
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
545
Price
$587.71
Total Value
$320.30K
Shares Held After
41,153
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
375
Price
$586.84
Total Value
$220.06K
Shares Held After
41,698
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
512
Price
$585.83
Total Value
$299.95K
Shares Held After
42,073
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
208
Price
$584.57
Total Value
$121.59K
Shares Held After
42,585
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$583.65
Total Value
$256.80K
Shares Held After
42,793
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
171
Price
$581.47
Total Value
$99.43K
Shares Held After
43,233
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
509
Price
$580.55
Total Value
$295.50K
Shares Held After
43,404
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$579.11
Total Value
$69.49K
Shares Held After
43,913
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
510
Price
$578.26
Total Value
$294.91K
Shares Held After
44,033
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
490
Price
$577.27
Total Value
$282.86K
Shares Held After
44,543
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
751
Price
$575.93
Total Value
$432.53K
Shares Held After
45,033
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,245
Price
$575.15
Total Value
$716.06K
Shares Held After
45,784
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
888
Price
$574.01
Total Value
$509.72K
Shares Held After
47,029
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
876
Price
$573.01
Total Value
$501.96K
Shares Held After
47,917
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$571.79
Total Value
$411.69K
Shares Held After
48,793
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
500
Price
$569.70
Total Value
$284.85K
Shares Held After
49,513
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
160
Price
$597.54
Total Value
$95.61K
Shares Held After
18,876
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$589.72
Total Value
$70.77K
Shares Held After
19,036
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$589.02
Total Value
$188.49K
Shares Held After
19,156
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
700
Price
$587.74
Total Value
$411.42K
Shares Held After
19,476
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
340
Price
$586.73
Total Value
$199.49K
Shares Held After
20,176
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
640
Price
$585.83
Total Value
$374.93K
Shares Held After
20,516
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$584.21
Total Value
$233.68K
Shares Held After
21,156
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$583.41
Total Value
$116.68K
Shares Held After
21,556
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
281
Price
$581.50
Total Value
$163.40K
Shares Held After
21,756
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
399
Price
$580.37
Total Value
$231.57K
Shares Held After
22,037
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
520
Price
$578.65
Total Value
$300.90K
Shares Held After
22,436
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
640
Price
$577.42
Total Value
$369.55K
Shares Held After
22,956
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,002
Price
$575.98
Total Value
$577.13K
Shares Held After
23,596
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,045
Price
$575.14
Total Value
$601.02K
Shares Held After
24,598
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,306
Price
$573.94
Total Value
$749.57K
Shares Held After
25,643
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
807
Price
$572.93
Total Value
$462.35K
Shares Held After
26,949
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
560
Price
$571.77
Total Value
$320.19K
Shares Held After
27,756
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
560
Price
$569.71
Total Value
$319.04K
Shares Held After
28,316
% of Holdings
1.9%
EXELIXIS, INC. (EXEL)
POSTE GEORGE — Director
Shares
60,000
Price
$45.71
Total Value
$2.74M
Shares Held After
118,832
% of Holdings
33.6%
EXELIXIS, INC. (EXEL)
Beckerle Mary C — Director
Shares
7,712
Price
$48.45
Total Value
$373.65K
Shares Held After
17,524
% of Holdings
30.6%
EXELIXIS, INC. (EXEL)
Freire Maria C — Director
Shares
20,634
Price
$46.00
Total Value
$949.16K
Shares Held After
100,819
% of Holdings
17.0%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
1,422
Price
$40.50
Total Value
$57.59K
Shares Held After
1,118
% of Holdings
56.0%
Vericel Corp (VCEL)
Mara Joseph Anthony Jr — Chief Financial Officer
Shares
5,000
Price
$40.50
Total Value
$202.50K
Shares Held After
21,009
% of Holdings
19.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
9
Price
$155.25
Total Value
$1.40K
Shares Held After
0
% of Holdings
100.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
3
Price
$154.61
Total Value
$463.83
Shares Held After
9
% of Holdings
25.0%
Showing 551–600 of 1194 transactions (page 12 of 24)